Stocks and Investing
Stocks and Investing
Tue, June 1, 2021
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
Fri, May 28, 2021
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
Vamil Divan Maintained (BHVN) at Strong Buy with Increased Target to $92 on, May 28th, 2021
Vamil Divan of Mizuho, Maintained "Biohaven Ltd." (BHVN) at Strong Buy with Increased Target from $90 to $92 on, May 28th, 2021.
Vamil has made no other calls on BHVN in the last 4 months.
There are 3 other peers that have a rating on BHVN. Out of the 3 peers that are also analyzing BHVN, 1 agrees with Vamil's Rating of Hold. Following is the relevant analyst calls for the last 4 months
- Matthew Harrison of "Morgan Stanley" Maintained at Hold with Decreased Target to $69 on, Tuesday, May 18th, 2021
These are the ratings of the 2 analyists that currently disagree with Vamil
- Marc Goodman of "SVB Leerink" Maintained at Buy with Decreased Target to $105 on, Wednesday, May 12th, 2021
- Esther Rajavelu of "UBS" Initiated at Strong Buy and Held Target at $108 on, Thursday, March 11th, 2021
Contributing Sources